Seema Sheoran
Stock Analyst at Rodman & Renshaw
(1.51)
# 3,513
Out of 4,598 analysts
6
Total ratings
33.3%
Success rate
-0.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Seema Sheoran
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ELDN Eledon Pharmaceuticals | Initiated Coverage: Buy | $12 | $3.38 | +255.03% | 1 | Jul 21, 2026 | |
| NGNE Neurogene | Initiated Coverage: Buy | $70 | $32.89 | +112.83% | 1 | Jun 3, 2026 | |
| AVXL Anavex Life Sciences | Initiated Coverage: Buy | $20 | $2.75 | +627.27% | 1 | May 4, 2026 | |
| CAMP Camp4 Therapeutics | Initiated Coverage: Buy | $7 | $3.45 | +102.90% | 1 | Apr 14, 2026 | |
| SABS SAB Biotherapeutics | Initiated Coverage: Buy | $13 | $3.57 | +264.15% | 1 | Apr 2, 2026 | |
| SGMT Sagimet Biosciences | Initiated Coverage: Buy | $28 | $7.11 | +293.81% | 1 | Mar 26, 2026 |
Eledon Pharmaceuticals
Jul 21, 2026
Initiated Coverage: Buy
Price Target: $12
Current: $3.38
Upside: +255.03%
Neurogene
Jun 3, 2026
Initiated Coverage: Buy
Price Target: $70
Current: $32.89
Upside: +112.83%
Anavex Life Sciences
May 4, 2026
Initiated Coverage: Buy
Price Target: $20
Current: $2.75
Upside: +627.27%
Camp4 Therapeutics
Apr 14, 2026
Initiated Coverage: Buy
Price Target: $7
Current: $3.45
Upside: +102.90%
SAB Biotherapeutics
Apr 2, 2026
Initiated Coverage: Buy
Price Target: $13
Current: $3.57
Upside: +264.15%
Sagimet Biosciences
Mar 26, 2026
Initiated Coverage: Buy
Price Target: $28
Current: $7.11
Upside: +293.81%